X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12441) 12441
Book Review (1797) 1797
Newspaper Article (837) 837
Newsletter (707) 707
Publication (482) 482
Magazine Article (149) 149
Book Chapter (87) 87
Trade Publication Article (26) 26
Conference Proceeding (23) 23
Book / eBook (13) 13
Web Resource (10) 10
Reference (5) 5
Data Set (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9869) 9869
humans (9574) 9574
hypothyroidism (7828) 7828
female (6784) 6784
male (5236) 5236
hypothyroidism - drug therapy (4546) 4546
adult (3884) 3884
middle aged (3491) 3491
thyroxine - therapeutic use (3155) 3155
endocrinology & metabolism (2359) 2359
aged (2295) 2295
thyrotropin - blood (2127) 2127
hypothyroidism - complications (1975) 1975
abridged index medicus (1930) 1930
thyroid hormones (1824) 1824
thyroid gland (1779) 1779
thyroxine - blood (1619) 1619
hypothyroidism - blood (1612) 1612
hyperthyroidism (1574) 1574
hypothyroidism - diagnosis (1414) 1414
adolescent (1370) 1370
pregnancy (1263) 1263
animals (1257) 1257
child (1232) 1232
thyroxine (1230) 1230
research (1200) 1200
medicine, general & internal (1163) 1163
thyroid function tests (1159) 1159
risk factors (1142) 1142
care and treatment (1137) 1137
hypothyroidism - etiology (973) 973
hypothyroidism - chemically induced (955) 955
thyroxine - administration & dosage (934) 934
hypothyroidism - physiopathology (929) 929
triiodothyronine - blood (912) 912
subclinical hypothyroidism (904) 904
disease (896) 896
treatment outcome (894) 894
drug therapy (891) 891
infant, newborn (891) 891
pediatrics (882) 882
congenital hypothyroidism (849) 849
therapy (847) 847
diagnosis (826) 826
patients (810) 810
thyrotropin (794) 794
thyroid diseases (746) 746
thyroid (737) 737
child, preschool (706) 706
hormones (696) 696
health aspects (683) 683
thyroid hormones - therapeutic use (678) 678
hormone replacement therapy (668) 668
diabetes (666) 666
retrospective studies (658) 658
infant (648) 648
follow-up studies (639) 639
rats (619) 619
medicine & public health (611) 611
thyroid hormones - blood (601) 601
prevalence (569) 569
aged, 80 and over (564) 564
time factors (560) 560
analysis (552) 552
hyperthyroidism - drug therapy (548) 548
endocrinology (546) 546
medical research (546) 546
children (544) 544
oncology (527) 527
cancer (524) 524
hypothyroidism - metabolism (523) 523
endocrine system (518) 518
hypothyroidism - epidemiology (491) 491
diagnosis, differential (488) 488
endocrine system diseases (480) 480
young adult (467) 467
management (455) 455
triiodothyronine (451) 451
drugs (435) 435
thyroidectomy (434) 434
triiodothyronine - therapeutic use (429) 429
dysfunction (427) 427
complications and side effects (426) 426
levothyroxine (419) 419
metabolism (418) 418
women (418) 418
thyroid-stimulating hormone (416) 416
thyroid gland - drug effects (413) 413
prospective studies (411) 411
physiological aspects (410) 410
studies (402) 402
internal medicine (399) 399
thyroid gland - physiopathology (380) 380
medicine, experimental (377) 377
drug dosages (376) 376
iodine (371) 371
risk (371) 371
pharmacology & pharmacy (367) 367
surgery (366) 366
mortality (365) 365
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12744) 12744
French (304) 304
German (300) 300
Spanish (183) 183
Russian (135) 135
Japanese (122) 122
Italian (91) 91
Polish (81) 81
Chinese (58) 58
Dutch (44) 44
Czech (24) 24
Portuguese (24) 24
Swedish (24) 24
Hungarian (22) 22
Danish (20) 20
Norwegian (16) 16
Turkish (15) 15
Korean (11) 11
Finnish (10) 10
Hebrew (9) 9
Slovak (9) 9
Romanian (8) 8
Ukrainian (8) 8
Serbian (5) 5
Bulgarian (4) 4
Lithuanian (1) 1
Macedonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thyroid, ISSN 1050-7256, 09/2011, Volume 21, Issue 9, pp. 951 - 956
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 18, pp. 1663 - 1673
This trial compared two thyrotropin-stimulation methods and two 131I doses for postoperative ablation in patients with low-risk thyroid cancer. Rates of... 
RECOMBINANT HUMAN THYROTROPIN | CARCINOMA PATIENTS | MEDICINE, GENERAL & INTERNAL | STIMULATED THYROGLOBULIN | REMNANT ABLATION | HORMONE WITHDRAWAL | FOLLOW-UP | PREDICTIVE-VALUE | SERUM THYROGLOBULIN LEVELS | QUALITY-OF-LIFE | RADIOACTIVE IODINE | Adenocarcinoma, Follicular - radiotherapy | Follow-Up Studies | Neck - diagnostic imaging | Humans | Middle Aged | Ablation Techniques | Male | Iodine Radioisotopes - adverse effects | Iodine Radioisotopes - therapeutic use | Thyrotropin - adverse effects | Thyroid Hormones - blood | Adenocarcinoma, Follicular - drug therapy | Ultrasonography | Adult | Female | Thyrotropin - therapeutic use | Thyroid Hormones - therapeutic use | Adenocarcinoma, Follicular - surgery | Thyroid Neoplasms - surgery | Carcinoma, Papillary - drug therapy | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Carcinoma, Papillary - surgery | Thyroidectomy | Hypothyroidism - etiology | Carcinoma, Papillary - radiotherapy | Thyroid Neoplasms - drug therapy | Quality of Life | Drugs | Dose-response relationship (Biochemistry) | Treatment outcome | Evaluation | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Risk groups | Event-related potentials | Thyroid gland | Contamination | Thyroid carcinoma | Metastases | Thyroid-stimulating hormone | Thyroglobulin | Neck | Cancer | Thyroid | Index Medicus | Abridged Index Medicus
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 07/1994, Volume 331, Issue 3, pp. 174 - 180
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 1994, Volume 330, Issue 24, pp. 1731 - 1738
The interval between follow-up visits can then be extended to three months. Because serum thyrotropin concentrations may remain low for weeks or months after... 
MEDICINE, GENERAL & INTERNAL | RADIOIODINE THERAPY | THYROXINE REPLACEMENT | RADIOACTIVE IODINE THERAPY | ANTI-THYROID DRUG | ANTITHYROID DRUGS | GRAVES-DISEASE | DOSE I-131 THERAPY | HYPER-THYROIDISM | INDUCED AGRANULOCYTOSIS | LONG-TERM FOLLOW | Disease | Surgery | Hyperthyroidism | Thyroid gland | Hypothyroidism | Drug therapy | Patients | Drug dosages | Iodine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 26, pp. 2534 - 2544
Journal Article
Thyroid, ISSN 1050-7256, 03/2017, Volume 27, Issue 3, pp. 315 - 389
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 18, pp. 1674 - 1685
In this trial, low-dose radioiodine was as effective as high-dose radioiodine in patients with differentiated thyroid tumors, and recombinant human thyrotropin... 
MEDICINE, GENERAL & INTERNAL | I-131 | THERAPY | SURVEILLANCE | PROGNOSTIC-SIGNIFICANCE | PAPILLARY | RADIOACTIVE IODINE | CARCINOMA | SERUM THYROGLOBULIN | IODINE REMNANT ABLATION | CONSENSUS REPORT | Ablation Techniques - psychology | Follow-Up Studies | Humans | Middle Aged | Male | Iodine Radioisotopes - adverse effects | Young Adult | Thyroid Hormones - blood | Aged, 80 and over | Adult | Female | Thyrotropin Alfa - therapeutic use | Ablation Techniques - adverse effects | Thyroid Hormones - therapeutic use | Thyrotropin Alfa - adverse effects | Length of Stay | Radiotherapy Dosage | Thyroid Neoplasms - surgery | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Thyroidectomy | Hypothyroidism - etiology | Iodine Radioisotopes - administration & dosage | Thyroid Neoplasms - drug therapy | Adolescent | Quality of Life | Aged | Drugs | Dose-response relationship (Biochemistry) | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Medical research | Data processing | Thyroid gland | Hypothyroidism | Patients | Lymph nodes | Quality of life | Metastases | Thyroid-stimulating hormone | Surgery | Triiodothyronine | Cancer | Thyroid | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 15, pp. 1408 - 1418
Among men with nonmetastatic prostate cancer who had a rapid PSA doubling time and were receiving androgen-deprivation therapy, the median metastasis-free... 
MEDICINE, GENERAL & INTERNAL | THERAPY | LIGANDS | BONE METASTASES | MEN | ARN-509 | ANTIGEN | Prostate-Specific Antigen | Double-Blind Method | Humans | Middle Aged | Proportional Hazards Models | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Prostatic Neoplasms, Castration-Resistant - pathology | Disease-Free Survival | Thiohydantoins - adverse effects | Exanthema - chemically induced | Neoplasm Metastasis - prevention & control | Thiohydantoins - therapeutic use | Aged, 80 and over | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Prostate cancer | Care and treatment | Metastasis | Medical research | Antigens | Lymphatic system | Medical imaging | Prostate-specific antigen | Research & development--R&D | Family medical history | Hypothyroidism | Survival | Patients | Metastases | Androgens | Hospitals | Castration | Prostate | Index Medicus | Abridged Index Medicus | Adenocarcinoma | pathology | Androgen Antagonists | Exanthema | 80 and over | Prostatic Neoplasms | Neoplasm Metastasis | Thiohydantoins | Urologi och njurmedicin | drug therapy | chemically induced | Castration-Resistant | prevention & control | secondary | adverse effects | Urology and Nephrology | therapeutic use
Journal Article